REGENXBIO Inc. Income Taxes Paid
REGENXBIO Inc. (RGNX) reported Income Taxes Paid of $904.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2020-02-26
- REGENXBIO Inc. income taxes paid for fiscal 2019 was $904.00K, a 73.74% decline from fiscal 2018.
- REGENXBIO Inc. income taxes paid for fiscal 2018 was $3.44M.
| Period end | Income Taxes Paid 12 month |
|---|---|
| 2019-12-31 | $904.00K 10-K · filed 2020-02-26 |
| 2018-12-31 | $3.44M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |